Affinity Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-29,328
Closed -$2.91M 152
2019
Q3
$2.91M Sell
29,328
-6,060
-17% -$576K 0.91% 44
2019
Q2
$3.27M Sell
35,388
-5,473
-13% -$520K 0.94% 43
2019
Q1
$3.85M Sell
40,861
-66,088
-62% -$5.78M 0.79% 51
2018
Q4
$6.85M Sell
106,949
-11,773
-10% -$869K 1.2% 41
2018
Q3
$10.6M Buy
118,722
+25,385
+27% +$2.24M 1.4% 35
2018
Q2
$7.41M Sell
93,337
-2,155
-2% -$179K 1.05% 43
2018
Q1
$8.52M Buy
95,492
+14,129
+17% +$1.36M 1% 44
2017
Q4
$8.49M Sell
81,363
-7,217
-8% -$814K 0.96% 47
2017
Q3
$12.9M Buy
88,580
+7,609
+9% +$1.04M 1.5% 24
2017
Q2
$10.5M Sell
80,971
-14,454
-15% -$1.77M 1.25% 40
2017
Q1
$11.9M Buy
+95,425
New +$11.4M 1.07% 40
2016
Q2
Sell
-4,802
Closed -$481K 178
2016
Q1
$481K Sell
4,802
-130,236
-96% -$13.4M 0.04% 117
2015
Q4
$16.2M Buy
135,038
+72
+0.1% +$8.33K 1.39% 32
2015
Q3
$14.6M Sell
134,966
-23,380
-15% -$2.9M 1.33% 31
2015
Q2
$18.3M Sell
158,346
-11,577
-7% -$1.32M 1.46% 19
2015
Q1
$19.6M Buy
169,923
+19,319
+13% +$2.31M 1.41% 26
2014
Q4
$16.8M Sell
150,604
-9,966
-6% -$1.05M 1.56% 24
2014
Q3
$15.2M Sell
160,570
-54,874
-25% -$4.95M 1.54% 22
2014
Q2
$18.5M Buy
215,444
+29,844
+16% +$2.27M 2.1% 9
2014
Q1
$13M Sell
185,600
-1,184
-0.6% -$93.8K 1.53% 31
2013
Q4
$15.8M Sell
186,784
-8,494
-4% -$672K 1.92% 14
2013
Q3
$15.1M Sell
195,278
-135,272
-41% -$9.48M 1.95% 12
2013
Q2
$19.3M Buy
+330,550
New +$19.9M 1.68% 21

Other funds holding CELG

Affinity Investment Advisors's CELG Position: Q4 2019 in Review

Affinity Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 29,328 shares — an estimated $2.91M sold.

Affinity Investment Advisors first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $19.6M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Affinity Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Affinity Investment Advisors sold 29,328 Celgene Corp shares in Q4 2019, an estimated $2.91M.
  • Affinity Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Affinity Investment Advisors's Celgene Corp position peaked at $19.6M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Affinity Investment Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.